Dental Care Clinics in Whitefish, MT Accepting Medicare
8 Dental Care Clinics found. Showing 1 - 8
 Alpenglow Dental, Pc Dentist Medicare: Not Enrolled in Medicare Practice Location: 3000 Hospital Way, Whitefish, MT 59937 Phone: 406-862-3839 Fax: 406-862-1428 |
Montana Center For Laser Dentistry Pllc Dentist Medicare: Not Enrolled in Medicare Practice Location: 6516 Us Highway 93 S, Whitefish, MT 59937 Phone: 406-862-1010 |
Stebbins Dental Studio, Inc. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 401 Baker Ave Ste A, Whitefish, MT 59937 Phone: 406-862-3503 |
Pamela M Lilly Dds Pc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 905 Wisconsin Avenue, Suite C, Whitefish, MT 59937 Phone: 406-862-8180 Fax: 406-862-8186 |
Eric Daniels Dds Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 401 Baker Ave, Whitefish, MT 59937 Phone: 406-862-3503 |
Jeff A Dalen Dds Pllc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 6345 Us Highway 93 S, Whitefish, MT 59937 Phone: 406-862-4301 Fax: 406-862-9347 |
Kalli D Elford, Dmd, Pc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 6516 Us Highway 93 S, Whitefish, MT 59937 Phone: 406-862-1010 |
Smile Montana Dental Center @ Whitefish Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 6360 Us Hwy 93 South, Whitefish, MT 59937 Phone: 406-892-2104 Fax: 406-892-1422 |
News Archive
Scientists could build better drugs by learning from bacteria-derived molecules
Bacteria found in soil may harbor a potential game-changer for drug design. A new study by Scripps Research, published today in Nature Communications, suggests scientists could build better drugs by learning from bacteria-derived molecules called thiocarboxylic acids.
A seismic view of the brain
A new study published in the journal Digital Medicine in March 2020 reports a prototype or pilot study that could make it easier to develop much more accurate imaging technology for the human brain, far more superior to any existing technology such as CT, MRI, and PET scanning.
FDA Advisory Committee recommends non-approval of liprotamase for exocrine pancreatic insufficiency
Eli Lilly and Company announced the U.S. Food and Drug Administration (FDA) Gastrointestinal Drugs Advisory Committee voted today to recommend non-approval of liprotamase, a non-porcine pancreatic enzyme replacement therapy (PERT), currently under FDA review for the treatment of exocrine pancreatic insufficiency (EPI).
Junk-food diet during pregnancy may change development of opioid pathway in baby's brain
Research to be presented at the Annual Meeting of the Society for the Study of Ingestive Behavior (SSIB), the foremost society for research into all aspects of eating and drinking behavior, shows that eating a junk-food diet during pregnancy changes the development of the opioid signalling pathway in the baby's brain and permanently alters the way this system operates after birth.
ADACTA trial: Tocilizumab more effective than adalimumab in treating RA
Data presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, demonstrates that tocilizumab monotherapy is more effective than adalimumab monotherapy in the treatment of rheumatoid arthritis (RA) based on change from baseline in DAS28 (-3.3 vs. -1.8, p<0.0001) at week 24.
› Verified 4 days ago